ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

NIH Chemical Genomics Center to screen small molecules.

June 18, 2004

Brain tumor foundations form collaboration.

July 15, 2005

Varmus: Plan Would Give Trials A Strong Scientific Base

December 17, 2010